In order to see if we could study ECM networks in our novel 3D model, we have quantified Fibrillin-1 in controls (n=2) and AAA patients (n=2) after 5 weeks of culturing on 3D scaffolds. This evidence concerns the gene FBN1 and triple-A syndrome.